Volitionrx (VNRX) Free Cash Flow Growth (5y) (2016 - 2025)
Volitionrx (VNRX) Free Cash Flow Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.35 Bn | 175.06 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn |
| 3 | Medtronic | 107.93 Bn | 98.71 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.82 Bn | 66.37 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.03 Bn | 44.36 Bn | 1.29 Bn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.90 Bn | 25.62 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 23.96 Bn | 20.83 Bn | 2.07 Bn |
| 10 | Volitionrx | 90,048.17 | -1.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.61% |
| Sep 30, 2025 | 4.55% |
| Jun 30, 2025 | -3.42% |
| Mar 31, 2025 | 0.77% |
| Dec 31, 2024 | -17.61% |
| Sep 30, 2024 | -8.97% |
| Jun 30, 2024 | -20.58% |
| Mar 31, 2024 | -18.85% |
| Dec 31, 2023 | 30.85% |
| Sep 30, 2023 | -11.69% |
| Jun 30, 2023 | -22.92% |
| Mar 31, 2023 | -19.64% |
| Dec 31, 2022 | -9.95% |
| Sep 30, 2022 | -19.52% |
| Jun 30, 2022 | -16.49% |
| Mar 31, 2022 | 24.43% |
| Dec 31, 2021 | -12.51% |
| Sep 30, 2021 | -18.64% |
| Jun 30, 2021 | -18.58% |
| Mar 31, 2021 | -25.20% |